5-amino-1mq nnmt inhibitor study weight loss 5-Amino-1MQ NNMT Inhibitor | Research

AHK-Cu and GHK-Cu are copper peptides that support collagen , scalp health, and follicle environment-they do not block DHT (dihydrotestosterone), the hormone linked to male pattern hair loss

In contrast to the placebo-treated subjects who experienced minimal changes in body weight over the 16-week treatment period, the pramlintide-treated subjects attained significant weight loss from baseline as early as week 2, which was progressive up to week 16, with no evidence of a plateau

This metabolic safety profile makes AOD-9604 potentially suitable for individuals with metabolic syndrome or diabetes risk factors who might not tolerate traditional growth hormone therapy, though medical supervision remains appropriate

2008 Sep;16(9):2081-7